Search research articles
Contact Us
Filters
Showing results (31-40 of 59) with videos related to
Page
of 6
Sort By:
Biochemistry
|
June 24, 2009
SWI/SNF-independent nuclease hypersensitivity and an increased level of histone acetylation at the P1 promoter accompany active transcription of the bone master gene Runx2
Fernando Cruzat, Berta Henriquez, Alejandro Villagra, et al.
Melanoma Research
|
August 22, 2013
The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity
David M Woods, Karrune Woan, Fengdong Cheng, et al.
The Journal of Biological Chemistry
|
June 15, 2006
Chromatin remodeling and transcriptional activity of the bone-specific osteocalcin gene require CCAAT/enhancer-binding protein beta-dependent recruitment of SWI/SNF activity
Alejandro Villagra, Fernando Cruzat, Loreto Carvallo, et al.
Nano Research
|
September 12, 2022
CD137 agonist potentiates the abscopal efficacy of nanoparticle-based photothermal therapy for melanoma
Preethi Bala Balakrishnan, Debbie K Ledezma, Juliana Cano-Mejia, et al.
Cancer Research
|
June 26, 2012
Stat3 inhibition augments the immunogenicity of B-cell lymphoma cells, leading to effective antitumor immunity
Fengdong Cheng, Hongwei Wang, Pedro Horna, et al.
Journal of Medicinal Chemistry
|
August 21, 2020
Rational Design of Suprastat: A Novel Selective Histone Deacetylase 6 Inhibitor with the Ability to Potentiate Immunotherapy in Melanoma Models
Satish Noonepalle, Sida Shen, Jakub Ptáček, et al.
Research Square
|
July 10, 2026
Aging reprograms the functional, epigenetic, and metabolic landscape of macrophages
Manasa Suresh, Francisco Tapia Belmonte, Bryan T Weselman, et al.
Journal of Medicinal Chemistry
|
August 16, 2019
Discovery of a New Isoxazole-3-hydroxamate-Based Histone Deacetylase 6 Inhibitor SS-208 with Antitumor Activity in Syngeneic Melanoma Mouse Models
Sida Shen, Melissa Hadley, Kseniya Ustinova, et al.
Cancer Research
|
November 26, 2009
Targeting the Fanconi anemia/BRCA pathway circumvents drug resistance in multiple myeloma
Danielle N Yarde, Vasco Oliveira, Linda Mathews, et al.
Blood Advances
|
November 15, 2018
Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia
Kamira Maharaj, John J Powers, Alex Achille, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 59) with videos related to
Sort By:
Page
of 6
Biochemistry
|
June 24, 2009
SWI/SNF-independent nuclease hypersensitivity and an increased level of histone acetylation at the P1 promoter accompany active transcription of the bone master gene Runx2
Fernando Cruzat, Berta Henriquez, Alejandro Villagra, et al.
Melanoma Research
|
August 22, 2013
The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity
David M Woods, Karrune Woan, Fengdong Cheng, et al.
The Journal of Biological Chemistry
|
June 15, 2006
Chromatin remodeling and transcriptional activity of the bone-specific osteocalcin gene require CCAAT/enhancer-binding protein beta-dependent recruitment of SWI/SNF activity
Alejandro Villagra, Fernando Cruzat, Loreto Carvallo, et al.
Nano Research
|
September 12, 2022
CD137 agonist potentiates the abscopal efficacy of nanoparticle-based photothermal therapy for melanoma
Preethi Bala Balakrishnan, Debbie K Ledezma, Juliana Cano-Mejia, et al.
Cancer Research
|
June 26, 2012
Stat3 inhibition augments the immunogenicity of B-cell lymphoma cells, leading to effective antitumor immunity
Fengdong Cheng, Hongwei Wang, Pedro Horna, et al.
Journal of Medicinal Chemistry
|
August 21, 2020
Rational Design of Suprastat: A Novel Selective Histone Deacetylase 6 Inhibitor with the Ability to Potentiate Immunotherapy in Melanoma Models
Satish Noonepalle, Sida Shen, Jakub Ptáček, et al.
Research Square
|
July 10, 2026
Aging reprograms the functional, epigenetic, and metabolic landscape of macrophages
Manasa Suresh, Francisco Tapia Belmonte, Bryan T Weselman, et al.
Journal of Medicinal Chemistry
|
August 16, 2019
Discovery of a New Isoxazole-3-hydroxamate-Based Histone Deacetylase 6 Inhibitor SS-208 with Antitumor Activity in Syngeneic Melanoma Mouse Models
Sida Shen, Melissa Hadley, Kseniya Ustinova, et al.
Cancer Research
|
November 26, 2009
Targeting the Fanconi anemia/BRCA pathway circumvents drug resistance in multiple myeloma
Danielle N Yarde, Vasco Oliveira, Linda Mathews, et al.
Blood Advances
|
November 15, 2018
Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia
Kamira Maharaj, John J Powers, Alex Achille, et al.
Page
of 6